Sesame, a healthcare marketplace, has launched a new clinical weight loss program offering compounded versions of the obesity drug Wegovy for $249 per month. The program aims to provide an affordable alternative amid a shortage of brand-name GLP-1 drugs like Wegovy and Ozempic, which typically cost $1,000 per month. Sesame's initiative includes consultations, lab work, and a content library for ongoing support. The program partners with a 503B compounding pharmacy to ensure safety and quality, addressing concerns about the purity of compounded medications.
Category
🗞
NewsTranscript
00:00It's Benzinga, and here's what's on the block.
00:02Sesame, a healthcare marketplace, has launched a new clinical weight loss program offering
00:07compounded versions of the obesity drug WeGubby for $249 per month.
00:12The program aims to provide an affordable alternative amid a shortage of brand-name
00:16GLP-1 drugs like WeGubby and Ozempic, which typically cost around $1,000 per month.
00:22Sesame's initiative includes consultations, lab work, and a content library for ongoing
00:26support.
00:27The program partners with a 503B compounding pharmacy to ensure safety and quality, addressing
00:33concerns about the purity of compounded medications.
00:35For all things money, visit Benzinga.com.